These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 25415718)
21. Screening Mammography in Women 40-49 Years Old: Current Evidence. Ray KM; Joe BN; Freimanis RI; Sickles EA; Hendrick RE AJR Am J Roentgenol; 2018 Feb; 210(2):264-270. PubMed ID: 29064760 [TBL] [Abstract][Full Text] [Related]
22. Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling. Mandelblatt JS; Near AM; Miglioretti DL; Munoz D; Sprague BL; Trentham-Dietz A; Gangnon R; Kurian AW; Weedon-Fekjaer H; Cronin KA; Plevritis SK Med Decis Making; 2018 Apr; 38(1_suppl):9S-23S. PubMed ID: 29554466 [TBL] [Abstract][Full Text] [Related]
23. A Molecular Subtype-Specific Stochastic Simulation Model of US Breast Cancer Incidence, Survival, and Mortality Trends from 1975 to 2010. Munoz DF; Xu C; Plevritis SK Med Decis Making; 2018 Apr; 38(1_suppl):89S-98S. PubMed ID: 29554473 [TBL] [Abstract][Full Text] [Related]
24. Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the cisnet breast cancer base case analysis. Cronin KA; Feuer EJ; Clarke LD; Plevritis SK J Natl Cancer Inst Monogr; 2006; (36):112-21. PubMed ID: 17032901 [TBL] [Abstract][Full Text] [Related]
25. Screening mammography in women less than age 50 years. Kerlikowske K Curr Opin Obstet Gynecol; 2012 Feb; 24(1):38-43. PubMed ID: 22037165 [TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of digital mammography screening before the age of 50 in The Netherlands. Sankatsing VD; Heijnsdijk EA; van Luijt PA; van Ravesteyn NT; Fracheboud J; de Koning HJ Int J Cancer; 2015 Oct; 137(8):1990-9. PubMed ID: 25895135 [TBL] [Abstract][Full Text] [Related]
27. Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012. Plevritis SK; Munoz D; Kurian AW; Stout NK; Alagoz O; Near AM; Lee SJ; van den Broek JJ; Huang X; Schechter CB; Sprague BL; Song J; de Koning HJ; Trentham-Dietz A; van Ravesteyn NT; Gangnon R; Chandler Y; Li Y; Xu C; Ergun MA; Huang H; Berry DA; Mandelblatt JS JAMA; 2018 Jan; 319(2):154-164. PubMed ID: 29318276 [TBL] [Abstract][Full Text] [Related]
28. Breast cancer statistics, 2011. DeSantis C; Siegel R; Bandi P; Jemal A CA Cancer J Clin; 2011; 61(6):409-18. PubMed ID: 21969133 [TBL] [Abstract][Full Text] [Related]
29. Breast cancer screening using tomosynthesis in combination with digital mammography. Friedewald SM; Rafferty EA; Rose SL; Durand MA; Plecha DM; Greenberg JS; Hayes MK; Copit DS; Carlson KL; Cink TM; Barke LD; Greer LN; Miller DP; Conant EF JAMA; 2014 Jun; 311(24):2499-507. PubMed ID: 25058084 [TBL] [Abstract][Full Text] [Related]
30. Reduction in false-positive results after introduction of digital mammography: analysis from four population-based breast cancer screening programs in Spain. Sala M; Salas D; Belvis F; Sánchez M; Ferrer J; Ibañez J; Román R; Ferrer F; Vega A; Laso MS; Castells X Radiology; 2011 Feb; 258(2):388-95. PubMed ID: 21273520 [TBL] [Abstract][Full Text] [Related]
31. Comparison of digital screening mammography and screen-film mammography in the early detection of clinically relevant cancers: a multicenter study. Bluekens AM; Holland R; Karssemeijer N; Broeders MJ; den Heeten GJ Radiology; 2012 Dec; 265(3):707-14. PubMed ID: 23033499 [TBL] [Abstract][Full Text] [Related]
32. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. US Preventive Services Task Force Ann Intern Med; 2009 Nov; 151(10):716-26, W-236. PubMed ID: 19920272 [TBL] [Abstract][Full Text] [Related]
33. The risk of radiation-induced breast cancers due to biennial mammographic screening in women aged 50-69 years is minimal. Hauge IH; Pedersen K; Olerud HM; Hole EO; Hofvind S Acta Radiol; 2014 Dec; 55(10):1174-9. PubMed ID: 24311702 [TBL] [Abstract][Full Text] [Related]
34. Outcomes of Breast Cancer Screening Strategies Based on Cancer Intervention and Surveillance Modeling Network Estimates. Monticciolo DL; Hendrick RE; Helvie MA Radiology; 2024 Feb; 310(2):e232658. PubMed ID: 38376405 [TBL] [Abstract][Full Text] [Related]
35. A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened. Webb ML; Cady B; Michaelson JS; Bush DM; Calvillo KZ; Kopans DB; Smith BL Cancer; 2014 Sep; 120(18):2839-46. PubMed ID: 24018987 [TBL] [Abstract][Full Text] [Related]
36. A systematic assessment of benefits and risks to guide breast cancer screening decisions. Pace LE; Keating NL JAMA; 2014 Apr; 311(13):1327-35. PubMed ID: 24691608 [TBL] [Abstract][Full Text] [Related]
37. The positive predictive value for diagnosis of breast cancer full-field digital mammography versus film-screen mammography in the diagnostic mammographic population. Seo BK; Pisano ED; Kuzmiak CM; Koomen M; Pavic D; McLelland R; Lee Y; Cole EB; Mattingly D; Lee J Acad Radiol; 2006 Oct; 13(10):1229-35. PubMed ID: 16979072 [TBL] [Abstract][Full Text] [Related]
38. Full-field digital versus screen-film mammography: comparative accuracy in concurrent screening cohorts. Del Turco MR; Mantellini P; Ciatto S; Bonardi R; Martinelli F; Lazzari B; Houssami N AJR Am J Roentgenol; 2007 Oct; 189(4):860-6. PubMed ID: 17885057 [TBL] [Abstract][Full Text] [Related]
39. Screening mammography in women aged 40-49 years: analysis of cost-effectiveness. Rosenquist CJ; Lindfors KK Radiology; 1994 Jun; 191(3):647-50. PubMed ID: 8184041 [TBL] [Abstract][Full Text] [Related]
40. Utilization and Cost of Mammography Screening Among Commercially Insured Women 50 to 64 Years of Age in the United States, 2012-2016. Khushalani JS; Ekwueme DU; Richards TB; Sabatino SA; Guy GP; Zhang Y; Tangka F J Womens Health (Larchmt); 2020 Mar; 29(3):327-337. PubMed ID: 31613693 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]